{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:48:52Z","timestamp":1761896932424,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71373160"],"award-info":[{"award-number":["71373160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["15GWZK0901"],"award-info":[{"award-number":["15GWZK0901"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.clinthera.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T10:40:28Z","timestamp":1549017628000},"page":"445-455.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes"],"prefix":"10.1016","volume":"41","author":[{"given":"Huafeng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.01.003_bib1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2019.01.003_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"Prevalence and control of diabetes in Chinese adults","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2019.01.003_bib3","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"issue":"2 Suppl","key":"10.1016\/j.clinthera.2019.01.003_bib4","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1177\/1010539515572220","article-title":"The economic burden of inpatients with type 2 diabetes: a case study in a Chinese hospital","volume":"27","author":"Wang","year":"2015","journal-title":"Asia Pac J Public Health"},{"key":"10.1016\/j.clinthera.2019.01.003_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-8587(14)70144-5","article-title":"Diabetes in China: a societal solution for a personal challenge","volume":"2","author":"Chan","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clinthera.2019.01.003_bib6","first-page":"893","article-title":"2013 China guideline for prevention and treatment of type 2 diabetes","volume":"30","year":"2014","journal-title":"Chin J Endocrinol Metabol"},{"key":"10.1016\/j.clinthera.2019.01.003_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/dmrr.2763","article-title":"The past, present, and future of basal insulins","volume":"32","author":"Pettus","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinthera.2019.01.003_bib8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.numecd.2015.06.005","article-title":"Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: a meta-analysis of seven clinical trials","volume":"25","author":"Russell-Jones","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.clinthera.2019.01.003_bib9","doi-asserted-by":"crossref","first-page":"8726046","DOI":"10.1155\/2018\/8726046","article-title":"Efficacy and safety of insulin degludec versus insulin glargine: a systematic review and meta-analysis of fifteen clinical trials","volume":"2018","author":"Liu","year":"2018","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.clinthera.2019.01.003_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/dmrr.2469","article-title":"Basal insulin analogues in the management of diabetes mellitus: what progress have we made?","volume":"30","author":"Owens","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinthera.2019.01.003_bib11","doi-asserted-by":"crossref","DOI":"10.2217\/cer-2018-0001","article-title":"Development and validation of a health policy model of type 2 diabetes in Chinese setting","author":"Wu","year":"2018","journal-title":"J\u00a0Comp Eff Res"},{"key":"10.1016\/j.clinthera.2019.01.003_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1185\/03007995.2015.1102722","article-title":"Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in health technology assessments: a systematic review of the literature from 2008 to 2013","volume":"32","author":"Charokopou","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2019.01.003_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11655-014-1749-y","article-title":"Guideline for postmarketing Chinese medicine pharmacoeconomic evaluation","volume":"21","author":"Wang","year":"2015","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.clinthera.2019.01.003_bib14","first-page":"660","article-title":"The efficacy and safety of insulin degludec versus insulin glargine in insulin-naive subjects with type 2 diabetes: results of a Chinese cohort from a multinational randomized controlled trial","volume":"56","author":"Mu","year":"2017","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.clinthera.2019.01.003_bib15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/dom.12865","article-title":"An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus","volume":"19","author":"McEwan","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2019.01.003_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s13300-017-0236-9","article-title":"Cost-effectiveness of insulin degludec versus insulin glargine in adults with type 1 and type 2 diabetes mellitus","volume":"8","author":"Evans","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.clinthera.2019.01.003_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.diabres.2017.11.025","article-title":"Glycaemic responses in Asian and non-Asian people with type 2 diabetes initiating insulin glargine 100\u202funits\/mL: a patient-level pooled analysis of 16 randomised controlled trials","volume":"135","author":"Chan","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinthera.2019.01.003_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00592-018-1107-1","article-title":"Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials","volume":"55","author":"Zhang","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.clinthera.2019.01.003_bib19","article-title":"Medical care and payment for diabetes in China: enormous threat and great opportunity","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2019.01.003_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40261-015-0290-x","article-title":"Clopidogrel versus aspirin in patients with recent ischemic stroke and established peripheral artery disease: an economic evaluation in a Chinese setting","volume":"35","author":"Li","year":"2015","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2019.01.003_bib21","first-page":"320","article-title":"Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting","volume":"10","author":"Wu","year":"2018","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.clinthera.2019.01.003_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03007995.2016.1257978","article-title":"Cost-effectiveness analysis of dapagliflozin versus glimepiride as monotherapy in a Chinese population with type 2 diabetes mellitus","volume":"33","author":"Shao","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2019.01.003_bib23","doi-asserted-by":"crossref","first-page":"e0165629","DOI":"10.1371\/journal.pone.0165629","article-title":"Cost-effectiveness of dapagliflozin versus acarbose as a monotherapy in type 2 diabetes in China","volume":"11","author":"Gu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2019.01.003_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/jdi.12653","article-title":"Prevention of renal failure in Chinese patients with newly diagnosed type 2 diabetes: a cost-effectiveness analysis","volume":"9","author":"Wu","year":"2018","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.clinthera.2019.01.003_bib25","first-page":"1195","article-title":"Incidence and cost of hypoglycemia episode in patients with type 2 diabetes mellitus (T2DM)","volume":"32","author":"Ya-ming","year":"2012","journal-title":"Chin Rural Health Serv Adm."},{"key":"10.1016\/j.clinthera.2019.01.003_bib26","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s13300-018-0478-1","article-title":"Cost-effectiveness of insulin degludec vs. insulin glargine u100 in type 1 and type 2 diabetes mellitus in a UK setting","volume":"9","author":"Evans","year":"2018","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.clinthera.2019.01.003_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0272989X15606903","article-title":"Valuing health-related quality of life in type 2 diabetes patients in China","volume":"36","author":"Pan","year":"2016","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2019.01.003_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pcd.2012.12.005","article-title":"A\u00a0changed pattern of insulin use following the introduction of basal analog insulin treatment in primary care","volume":"7","author":"Heymann","year":"2013","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.clinthera.2019.01.003_bib29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s13300-018-0426-0","article-title":"Cost-effectiveness of insulin degludec versus insulin glargine u100 in patients with type 1 and type 2 diabetes mellitus in Serbia","volume":"9","author":"Lali\u0107","year":"2018","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.clinthera.2019.01.003_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14737167.2017.1345628","article-title":"Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus\u2014from the Spanish National Health System perspective","volume":"17","author":"Mezquita-Raya","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.clinthera.2019.01.003_bib31","first-page":"213","article-title":"A\u00a0short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark","volume":"20","author":"Pollock","year":"2017","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.clinthera.2019.01.003_bib32","first-page":"1442","article-title":"Evaluation of the cost-utility of insulin degludec vs insulin glargine in Sweden","volume":"16","author":"Ericsson","year":"2013","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.clinthera.2019.01.003_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jdi.12102","article-title":"Insulin degludec compared with insulin glargine in insulin-na\u00efve patients with type 2 diabetes: a 26-week, randomized, controlled, Pan-Asian, treat-to-target trial","volume":"4","author":"Onishi","year":"2013","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.clinthera.2019.01.003_bib34","doi-asserted-by":"crossref","first-page":"e002875","DOI":"10.1161\/JAHA.115.002875","article-title":"Association between severe hypoglycemia and cardiovascular disease risk in Japanese patients with type 2 diabetes","volume":"5","author":"Goto","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.clinthera.2019.01.003_bib35","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2337\/dc15-2418","article-title":"A\u00a0population-based study of all-cause mortality and cardiovascular disease in association with prior history of hypoglycemia among patients with type 1 diabetes","volume":"39","author":"Lu","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.003_bib36","doi-asserted-by":"crossref","first-page":"e5183","DOI":"10.1097\/MD.0000000000005183","article-title":"Association of self-reported recurrent mild hypoglycemia with incident cardiovascular disease and all-cause mortality in patients with type 2 diabetes: prospective analysis of the Joint Asia Diabetes Evaluation Registry","volume":"95","author":"Luk","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1 Suppl","key":"10.1016\/j.clinthera.2019.01.003_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/dom.13178","article-title":"What have we learnt from \u201creal world\u201d data, observational studies and meta-analyses","volume":"20","author":"Chatterjee","year":"2018","journal-title":"Diabetes Obes Metab"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819300074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819300074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T07:02:28Z","timestamp":1662879748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819300074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0149291819300074"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.01.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}